Literature DB >> 19029498

Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis.

Matthew T James1, Kevin B Laupland, Marcello Tonelli, Braden J Manns, Bruce F Culleton, Brenda R Hemmelgarn.   

Abstract

BACKGROUND: Patients with end-stage renal disease requiring dialysis are at high risk for bloodstream infection and infection-related death. Whether patients with chronic kidney disease who are not receiving dialysis are also at increased risk of bloodstream infection is less clear.
METHODS: We examined the association between chronic kidney disease not being treated with dialysis and bloodstream infection in a cohort of patients 66 years or older. All patients required at least 1 outpatient serum creatinine measurement enabling estimation of glomerular filtration rate (eGFR) using the Modification of Diet in Renal Disease Study equation. Cox proportional hazards models with censoring at the initiation of renal replacement therapy or death were used to determine associations between eGFR, bloodstream infection, and death within 30 days of community-onset bloodstream infection, adjusting for potential confounders.
RESULTS: In 25 675 patients followed up for a median of 3.2 years, 797 developed at least 1 bloodstream infection, of which most (75%) were community-onset infections. Compared with patients with an eGFR of 60 mL/min/1.73 m(2) or higher, adjusted hazard ratios (95% confidence intervals) for bloodstream infection according to eGFR were, respectively, 1.24 (1.01-1.52), 1.59 (1.24-2.04), and 3.54 (2.69-4.69) in those with an eGFR of 45 to 59, 30 to 44, and less than 30 mL/min/1.73 m(2). The associations were consistent for both community-onset and nosocomial infections. Compared with patients with an eGFR of 60 mL/min/1.73 m(2) or higher, the risk of death within 30 days of community-onset bloodstream infection was significantly greater in those with an eGFR less than 30 mL/min/1.73 m(2) (hazard ratio, 4.10; 95% confidence interval, 2.06-8.14).
CONCLUSION: Older adults with chronic kidney disease not being treated with dialysis are at increased risk of bloodstream infection and of death following community-onset bloodstream infection.

Entities:  

Mesh:

Year:  2008        PMID: 19029498     DOI: 10.1001/archinte.168.21.2333

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  49 in total

1.  Procalcitonin: diagnostic value in systemic infections in chronic kidney disease or renal transplant patients.

Authors:  Raluca Dumea; Dimitrie Siriopol; Simona Hogas; Irina Mititiuc; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2013-08-30       Impact factor: 2.370

2.  Acute kidney injury as an independent predictor of infection and malignancy: the NARA-AKI cohort study.

Authors:  Miho Tagawa; Masatoshi Nishimoto; Maiko Kokubu; Masaru Matsui; Masahiro Eriguchi; Ken-Ichi Samejima; Yasuhiro Akai; Kazuhiko Tsuruya
Journal:  J Nephrol       Date:  2019-10-15       Impact factor: 3.902

3.  Cumulative Fluid Balance and Mortality in Septic Patients With or Without Acute Kidney Injury and Chronic Kidney Disease.

Authors:  Javier A Neyra; Xilong Li; Fabrizio Canepa-Escaro; Beverley Adams-Huet; Robert D Toto; Jerry Yee; S Susan Hedayati
Journal:  Crit Care Med       Date:  2016-10       Impact factor: 7.598

Review 4.  Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.

Authors:  Ilaria Serio; Laurent Arnaud; Alexis Mathian; Pierre Hausfater; Zahir Amoura
Journal:  Clin Rheumatol       Date:  2014-07-27       Impact factor: 2.980

5.  Predictive value of procalcitonin for diagnosis of infections in patients with chronic kidney disease: a comparison with traditional inflammatory markers C-reactive protein, white blood cell count, and neutrophil percentage.

Authors:  Yanbei Sun; Lijuan Jiang; Xiaonan Shao
Journal:  Int Urol Nephrol       Date:  2017-09-27       Impact factor: 2.370

6.  Chronic kidney disease and risk of death from infection.

Authors:  Henry E Wang; Christopher Gamboa; David G Warnock; Paul Muntner
Journal:  Am J Nephrol       Date:  2011-08-22       Impact factor: 3.754

7.  CKD and Risk for Hospitalization With Infection: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Junichi Ishigami; Morgan E Grams; Alexander R Chang; Juan J Carrero; Josef Coresh; Kunihiro Matsushita
Journal:  Am J Kidney Dis       Date:  2016-11-22       Impact factor: 8.860

8.  eGFR and the Risk of Community-Acquired Infections.

Authors:  Hong Xu; Alessandro Gasparini; Junichi Ishigami; Khaled Mzayen; Guobin Su; Peter Barany; Johan Ärnlöv; Bengt Lindholm; Carl Gustaf Elinder; Kunihiro Matsushita; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-17       Impact factor: 8.237

9.  Independent risk factors for mortality in critically ill patients with candidemia on Italian Internal Medicine Wards.

Authors:  Francesco Sbrana; Emanuela Sozio; Matteo Bassetti; Andrea Ripoli; Filippo Pieralli; Anna Maria Azzini; Alessandro Morettini; Carlo Nozzoli; Maria Merelli; Sebastiano Rizzardo; Giacomo Bertolino; Davide Carrara; Claudio Scarparo; Ercole Concia; Francesco Menichetti; Carlo Tascini
Journal:  Intern Emerg Med       Date:  2018-01-10       Impact factor: 3.397

10.  Predictors of hospital-acquired urinary tract-related bloodstream infection.

Authors:  M Todd Greene; Robert Chang; Latoya Kuhn; Mary A M Rogers; Carol E Chenoweth; Emily Shuman; Sanjay Saint
Journal:  Infect Control Hosp Epidemiol       Date:  2012-08-23       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.